previous compound ID: 1453 next compound
InChIKey: NCMZQTLCXHGLOK-ZKHIMWLXSA-N
SMILES: CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "SD Macknight" "DY Thomas" "GW Carlile" "E Matthes" "JW Hanrahan" "R Robert" "D Rotin" "B Kus" "J Liao"

chemical graph of compound 1453





CID is 14709
synonyms found at PubChem are:
Dehydroepiandrosterone acetate, 853-23-6, Prasterone acetate, Dehydroisoandrosterone 3-acetate, Dehydroisoandrosterone acetate, Androstenolone acetate, trans-Dehydroandrosterone acetate, 3beta-Acetoxy-5-androstene-17-one, Dehydroisoandosterone 3-acetate, CCRIS 7926, Dehydroepiandrosterone 3-acetate, UNII-45751H45MY, 3-beta-Acetoxydehydroepiandrosterone, SKF 2847, EINECS 212-714-1, 5-Androsten-3beta-ol-7-one acetate, 17-Oxoandrost-5-en-3beta-yl acetate, delta5-Dehydroepiandrosterone 3-acetate, Dehydroepiandrost-5-en-17-one 3-acetate, 3beta-Hydroxy-5-androsten-17-one acetate, 3beta-Hydroxyandrost-5-en-17-one acetate, 3beta-Hydroxy-5-androstene-17-one acetate, 3-beta-Hydroxyandrost-5-en-17-one acetate, 3beta-Hydroxyandrost-5-en-17-one 3-acetate, NCMZQTLCXHGLOK-ZKHIMWLXSA-N, 3beta-acetoxyandrost-5-en-17-one, Androst-5-en-17-one, 3-(acetyloxy)-, (3-beta)-, 45751H45MY, [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate, (3beta)-17-oxoandrost-5-en-3-yl acetate, DSSTox_CID_380, DSSTox_RID_75554, Androst-5-en-17-one, 3-(acetyloxy)-, (3b)-, Androst-5-en-17-one, 3-beta-hydroxy-, acetate, DSSTox_GSID_20380, 17-Oxoandrost-5-en-3-yl acetate #, NCGC00016544-01, (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, CAS-853-23-6, Prestwick0_000937, Prestwick1_000937, Prestwick2_000937, Prestwick3_000937, Dehydroepiandrosteroneacetate, BSPBio_000874, MLS002154068, SCHEMBL298142, SPBio_003043, OOEaINCaOiEthUcThornI feminine, AC1L24E6, BPBio1_000962, CHEMBL1480686, DTXSID3020380, CHEBI:135410, MolPort-002-506-956, 3betaacetoxy-5-androstene-17-one, HMS1570L16, HMS2097L16, HMS2230I06, HMS3714L16, 3beta-acetoxy-5-androsten-17-one, HY-B1405, ZINC3881408, 3beta-acetoxy-androst-5-en-17-one, Tox21_110485, Tox21_200963, 3beta-acetoxy-5-androstene -17-one, AKOS015895423, CCG-220937, CHM0029112, CS-6082, Dehydroisoandrosterone 3-acetate, 97%, EBD2197393, LS-7297, MCULE-4605464077, NCGC00179388-01, NCGC00179388-02, NCGC00258516-01, AK307717, AN-47791, AS-20015, SMR001233383, (3?)-17-Oxoandrost-5-en-3-yl acetate, TL8005578, 5-Androsten-3.beta.-ol-17-one, 3-acetate, AB00171449, D0045, Z3653, A-7919, Androst-5-en-17-one,3-(acetyloxy)-, (3b)-, 853D236, Q-200934, BRD-K96527333-001-03-4, 3-|A-oC>>u-E yenNoEthUcThorn-5-I(c)-17-I feminine-3- xEao yen, (1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.02,7.011,15]heptadec-7-en-5-yl acetate